Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2014 May 14;24(8):1303–1308. doi: 10.1016/j.euroneuro.2014.05.001

Table 1.

demographic and cardiovascular characteristics of the sample by Apo E4 status.

ApoE4+*
Mean
(SD)
ApoE4−
*
Mean
(SD)
Total
sample
P*
n 107 701 808
Age 72.28
(4.72)
71.94
(4.68)
71.98
(4.69)
0.48
Sex (percent
females)
42 39 40 0.58
Years of
education
13.68
(3.49)
13.05
(3.43)
13.13
(3.44)
0.08
Years of
follow up in
the registry
10.26
(1.86)
10.51
(1.28)
10.48
(1.37)
0.08
BMI* 28.73
(4.53)
28.24
(4.37)
28.31
(4.38)
0.29
Creatinine 0.99 (0.19) 0.99
(0.25)
0.99
(0.25)
0.99
Diastolic
BP*
85.55
(15.35)
82.98
(15.34)
83.32
(15.35)
0.11
Systolic BP 166.01
(9.75)
165.79
(9.64)
165.82
(9.65)
0.83
Cholesterol 180.93
(27.48)
180.32
(24.40)
180.40
(24.81)
0.82
Triglycerides 159.24
(96.47)
156.29
(57.32)
156.68
(63.80)
0.66
Diabetes
medications
1.93 (0.06) 2.06
(0.70)
2.04
(0.68)
0.80
HbA1c (%) 6.75 (0.74) 6.79
(0.78)
6.79
(0.77)
0.58
*

BMI= Body mass index, BP= blood pressure, HbA1c=Hemoglobin A1c, p for difference between Apo E4+ and Apo E4 −